OR18-03 Peripheral But Not Hepatic Insulin Resistance Associates With Adverse Vascular And Metabolic Health In Type 1 Diabetes: A Possible Target For Adjunctive Therapy

Disclosure: J.R. Snaith: None. N. Olsen: None. G. Kowalski: None. C. Bruce: None. J. Holmes-Walker: None. J.R. Greenfield: None. Insulin resistance in type 1 diabetes (T1D) is a cardiometabolic risk factor that is potentially targetable with adjunctive therapy. Prior studies of metformin in T1D have...

Descripción completa

Detalles Bibliográficos
Autores principales: Snaith, Jennifer R, Olsen, Nicholas, Kowalski, Greg, Bruce, Clinton, Holmes-Walker, Jane, Greenfield, Jerry R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Diabetes And Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557016/
http://dx.doi.org/10.1210/jendso/bvad114.895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557016/
http://dx.doi.org/10.1210/jendso/bvad114.895

Ejemplares similares